|
|
 Previous Article | Table of Contents | Next Article 
RAPID COMMUNICATION
Hematopoietic Cell Phosphatase Negatively Regulates Erythropoietin-Induced Hemoglobinization in Erythroleukemic SKT6 Cells
Elizabeth R. Sharlow,
Robert Pacifici,
Jill Crouse,
Jennifer Batac,
Kazuo Todokoro, and
D.M. Wojchowski
From the Graduate Programs in Genetics and Biochemistry & Molecular Biology, Department of Veterinary Science, Amgen, Inc, Thousand Oaks, CA; Tsukuba Life Science Center, Tsukuba, Ibaraki, Japan; and Center for Gene Regulation, The Pennsylvania State University, University Park, PA.
In an increasing number of hematopoietic cytokine receptor systems (T-cell receptor, B-cell receptor, and macrophage colony-stimulating factor, stem cell factor, interleukin-3, and erythropoietin [EPO] receptors), inhibitory roles for the protein tyrosine phosphatase hematopoietic cell phosphatase (HCP; SHPTP1, PTP1C, and SHP1) have been defined in proliferative signaling. However, evidence exists to suggest that HCP also may exert important effects on blood cell differentiation. To investigate possible roles for HCP during late erythroid differentiation, effects of manipulating HCP expression or recruitment on EPO-induced hemoglobinization in erythroleukemic SKT6 cells have been investigated. No effects of EPO on levels of HCP, Syp, Stat5, the EPO receptor, or GATA-1 expression were observed during induced differentiation. However, the tyrosine phosphorylation of JAK2, the EPO receptor, and Stat5 was efficiently activated, and HCP was observed to associate constitutively with the EPO receptor in this differentiation-specific system. In studies of HCP function, inhibition of HCP expression by antisense oligonucleotides enhanced hemoglobinization, whereas the enforced ectopic expression of wild-type (wt) HCP markedly inhibited EPO-induced globin expression and Stat5 activation. Based on these findings, epidermal growth factor (EGF) receptor/EPO receptor chimeras containing either the wt EPO receptor cytoplasmic domain (EECA) or a derived HCP binding site mutant (EECA-Y429,431F ) were expressed in SKT6 cells, and their abilities to mediate differentiation were assayed. Each chimera supported EGF-induced hemoglobinization, but efficiencies for EECA-Y429,431F were enhanced 400% to 500%. Thus, these studies show a novel role for HCP as a negative regulator of EPO-induced erythroid differentiation. In normal erythroid progenitor cells, HCP may act to prevent premature commitment to terminal differentiation. In erythroleukemic SKT6 cells, this action also may enforce mitogenesis.
Blood, Vol. 90 No. 6 (September 15), 1997:
pp. 2175-2187
© 1997 by The American Society of Hematology.
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati What's this?
This article has been cited by other articles:
|
|
|
|
 
R. G. Wenzel
Biosimilars: Illustration of scientific issues in two examples
Am. J. Health Syst. Pharm.,
July 15, 2008;
65(14_Supplement_6):
S9 - S15.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
Y. Han, H. M. Amin, B. Franko, C. Frantz, X. Shi, and R. Lai
Loss of SHP1 enhances JAK3/STAT3 signaling and decreases proteosome degradation of JAK3 and NPM-ALK in ALK+ anaplastic large-cell lymphoma
Blood,
October 15, 2006;
108(8):
2796 - 2803.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
K. Nishigaki, C. Hanson, T. Ohashi, A. Spadaccini, and S. Ruscetti
Erythroblast Transformation by the Friend Spleen Focus-Forming Virus Is Associated with a Block in Erythropoietin-Induced STAT1 Phosphorylation and DNA Binding and Correlates with High Expression of the Hematopoietic Phosphatase SHP-1.
J. Virol.,
June 1, 2006;
80(12):
5678 - 5685.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. Akagi, H. Ichikawa, T. Okada, A. Sarai, T. Sugimoto, H. Morimoto, T. Kihara, A. Yano, K. Nakao, Y. Nagake, et al.
The Critical Role of Src Homology Domain 2-Containing Tyrosine Phosphatase-1 in Recombinant Human Erythropoietin Hyporesponsive Anemia in Chronic Hemodialysis Patients
J. Am. Soc. Nephrol.,
December 1, 2004;
15(12):
3215 - 3224.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. B. Marrero, R. L. Papke, B. S. Bhatti, S. Shaw, and M. Bencherif
The Neuroprotective Effect of 2-(3-Pyridyl)-1-azabicyclo[3.2.2]nonane (TC-1698), a Novel {alpha}7 Ligand, Is Prevented through Angiotensin II Activation of a Tyrosine Phosphatase
J. Pharmacol. Exp. Ther.,
April 1, 2004;
309(1):
16 - 27.
[Abstract]
[Full Text]
|
|
|
|
|
|
|
S. Shaw, M. Bencherif, and M. B. Marrero
Angiotensin II Blocks Nicotine-Mediated Neuroprotection against {beta}-Amyloid (1-42) via Activation of the Tyrosine Phosphatase SHP-1
J. Neurosci.,
December 3, 2003;
23(35):
11224 - 11228.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. M. Kant, P. De, X. Peng, T. Yi, D. J. Rawlings, J. S. Kim, and D. L. Durden
SHP-1 regulates Fcgamma receptor-mediated phagocytosis and the activation of RAC
Blood,
August 13, 2002;
100(5):
1852 - 1859.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
T. Ikuta, S. Ausenda, and M. D. Cappellini
Mechanism for fetal globin gene expression: Role of the soluble guanylate cyclase-cGMP-dependent protein kinase pathway
PNAS,
February 1, 2001;
(2001)
41599798.
[Abstract]
[Full Text]
|
|
|
|
|
|
|
A. Beghini, C. B. Ripamonti, P. Peterlongo, G. Roversi, R. Cairoli, E. Morra, and L. Larizza
RNA hyperediting and alternative splicing of hematopoietic cell phosphatase (PTPN6) gene in acute myeloid leukemia
Hum. Mol. Genet.,
September 1, 2000;
9(15):
2297 - 2304.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. C. Gregory, N. Jiang, K. Todokoro, J. Crouse, R. E. Pacifici, and D. M. Wojchowski
Erythropoietin Receptor and STAT5-Specific Pathways Promote SKT6 Cell Hemoglobinization
Blood,
August 15, 1998;
92(4):
1104 - 1118.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
K. Kirito, M. Uchida, M. Takatoku, K. Nakajima, T. Hirano, Y. Miura, and N. Komatsu
A Novel Function of Stat1alpha and Stat3 Proteins in Erythropoietin-Induced Erythroid Differentiation of a Human Leukemia Cell Line
Blood,
July 15, 1998;
92(2):
462 - 471.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
T. Ikuta, S. Ausenda, and M. D. Cappellini
Mechanism for fetal globin gene expression: Role of the soluble guanylate cyclase-cGMP-dependent protein kinase pathway
PNAS,
February 13, 2001;
98(4):
1847 - 1852.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
